Fmr LLC Sells 24,369 Shares of Xylem Inc. (NYSE:XYL)

FMR LLC decreased its stake in Xylem Inc. (NYSE:XYL - Free Report) by 10.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 208,192 shares of the industrial products company's stock after selling 24,369 shares during the period. FMR LLC owned approximately 0.09% of Xylem worth $28,112,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Brown Brothers Harriman & Co. boosted its stake in Xylem by 12.5% during the third quarter. Brown Brothers Harriman & Co. now owns 973 shares of the industrial products company's stock worth $131,000 after buying an additional 108 shares in the last quarter. Boston Family Office LLC boosted its stake in Xylem by 0.3% during the third quarter. Boston Family Office LLC now owns 79,333 shares of the industrial products company's stock worth $10,712,000 after buying an additional 209 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in Xylem by 21.3% during the third quarter. Daiwa Securities Group Inc. now owns 95,023 shares of the industrial products company's stock worth $12,830,000 after buying an additional 16,658 shares in the last quarter. Algert Global LLC boosted its stake in Xylem by 798.2% during the third quarter. Algert Global LLC now owns 31,481 shares of the industrial products company's stock worth $4,251,000 after buying an additional 27,976 shares in the last quarter. Finally, Cerity Partners LLC boosted its stake in Xylem by 22.9% during the third quarter. Cerity Partners LLC now owns 115,045 shares of the industrial products company's stock worth $15,534,000 after buying an additional 21,464 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Trading Down 0.6 %

NYSE:XYL traded down $0.78 on Tuesday, hitting $128.57. 1,741,077 shares of the stock were exchanged, compared to its average volume of 1,235,234. The stock has a market capitalization of $31.24 billion, a price-to-earnings ratio of 37.82, a P/E/G ratio of 2.33 and a beta of 1.05. Xylem Inc. has a 52 week low of $106.24 and a 52 week high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. The company's 50-day moving average price is $128.56 and its 200 day moving average price is $132.93.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, hitting the consensus estimate of $1.11. The firm had revenue of $2.10 billion during the quarter, compared to analysts' expectations of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company's quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.99 EPS. On average, equities research analysts forecast that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be issued a dividend of $0.36 per share. The ex-dividend date is Tuesday, November 26th. This represents a $1.44 annualized dividend and a yield of 1.12%. Xylem's dividend payout ratio is currently 42.11%.

Analysts Set New Price Targets

A number of research firms have weighed in on XYL. UBS Group began coverage on shares of Xylem in a research note on Tuesday, August 13th. They set a "buy" rating and a $165.00 price target on the stock. Citigroup upgraded shares of Xylem from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $135.00 to $148.00 in a research note on Monday. Robert W. Baird reduced their target price on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Royal Bank of Canada reduced their target price on shares of Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Finally, TD Cowen reduced their target price on shares of Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a research note on Wednesday, November 6th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $150.45.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.